Effect of Dermaseptin S4 on C. albicans Growth and EAP1 and HWP1 Gene Expression.

Probiotics and Antimicrobial Proteins
Johan Samot, Mahmoud Rouabhia

Abstract

Increasing resistance and changes in the spectrum of Candida infections have generated considerable interest in the development of new antifungal molecules. The use of antimicrobial peptides (AMPs) appears to be a promising approach. Frog skin AMPs (such as dermaseptins) have shown antimicrobial activity against several pathogens. In this study, we aimed to test the antimicrobial efficacy of dermaseptin S4 (DS4) against C. albicans. We determined the minimal inhibitory concentration (MIC) of DS4, and investigated the effects of the DS4 at low concentrations on human primary gingival fibroblasts. Additionally, we evaluated the effect of DS4 on C. albicans growth, form changes, and biofilm formation, as well as the expression of certain virulent genes. Our data show that DS4 completely inhibits C. albicans growth at a concentration of 32 μg/mL referring to the MIC of DS4. It should be noted that even with low concentrations (below 16 μg/mL), DS4 still have significant growth reduction of C. albicans, but were not toxic to human gingival fibroblasts. DS4 inhibited the transition from yeast to hyphae, and decreased the biofilm formation by reducing the biofilm mass weight. Surface morphological changes in the yeast cell membrane we...Continue Reading

References

Jan 15, 1994·European Journal of Biochemistry·A Mor, P Nicolas
Mar 4, 1999·Biophysical Chemistry·P La RoccaM S Sansom
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Dec 11, 2003·Eukaryotic Cell·Fang Li, Sean P Palecek
Oct 13, 2006·Eukaryotic Cell·Clarissa J NobileAaron P Mitchell
Sep 6, 2007·Antimicrobial Agents and Chemotherapy·Nicholas BeckloffGill Diamond
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
Sep 6, 2008·Microbiology and Molecular Biology Reviews : MMBR·W LaJean Chaffin
Oct 22, 2008·Biochimica Et Biophysica Acta·Pierre Nicolas, Chahrazade El Amri
Apr 8, 2011·Current Pharmaceutical Biotechnology·Mohamed Amiche, Cécile Galanth
May 9, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Maiken C ArendrupUNKNOWN EUCAST-AFST
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Jan 11, 2013·Virulence·François L MayerBernhard Hube
May 13, 2015·Scientific Reports·Kah Yean LumShamala Devi Sekaran
Oct 9, 2015·The New England Journal of Medicine·Bart Jan Kullberg, Maiken C Arendrup
Oct 22, 2015·Annual Review of Microbiology·Clarissa J Nobile, Alexander D Johnson
Jan 8, 2016·Infectious Disease Clinics of North America·Jeniel E Nett, David R Andes
Mar 11, 2016·Pathogens and Disease·Christina TsuiMary Ann Jabra-Rizk
Mar 22, 2016·Cellular Microbiology·Jiyoti Verma-Gaur, Ana Traven
Apr 23, 2016·Frontiers in Bioscience (Landmark Edition)·Ali Ladram, Pierre Nicolas
Jun 3, 2016·Microbiology and Molecular Biology Reviews : MMBR·David R Soll, Karla J Daniels
Jul 28, 2016·Antimicrobial Agents and Chemotherapy·Guan-Yu LinChung-Yu Lan
Nov 12, 2016·Methods in Molecular Biology·David A EnochChristianne Micallef
Sep 10, 2017·Annual Review of Microbiology·Nicole RobbinsLeah E Cowen
May 26, 2018·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Humidah AlanaziMahmoud Rouabhia
Mar 22, 2019·Open Forum Infectious Diseases·Michael A PfallerRonald N Jones
May 28, 2019·Current Opinion in Microbiology·David Kadosh
Mar 20, 2020·Journal of Peptide Science : an Official Publication of the European Peptide Society·Patrícia G LimaDaniele O B Sousa

❮ Previous
Next ❯

Citations

Sep 12, 2021·Bioscience, Biotechnology, and Biochemistry·Tomojiro Koide, Muneaki Tamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.